Thursday, October 15, 2026

Silver Futures Is 14% Up In The Last 21 Sessions

Silver Futures Is 14% Up In The Last 21 Sessions

(VIANEWS) - Silver (SI) has been up by 14.4% for the last 21 sessions. At 11:54 EST on Monday, 8 April, Silver (SI) is $27.88.

Volume

Today's last reported volume for Silver is 104703, 99.99% below its average volume of 9988923623.95.

Volatility

Silver's last week, last month's, and last quarter's current intraday variation average was 1.24%, 0.75%, and 1.40%, respectively.

Silver's highest amplitude of average volatility was 1.24% (last week), 1.17% (last month), and 1.40% (last quarter), respectively.

Commodity Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Silver's commodity is considered to be oversold (<=20).

Previous days news about Silver (SI)

  • Silver birch therapy brings rawness, humor, and realness to online talk therapy in Minnesota and North Dakota. According to Business Insider on Sunday, 7 April, "It takes work to keep a couple together, and the experts at Silver Birch Therapy specialize in helping couples deeply heal to build the relationship they want. ", "The staff at Silver Birch Therapy believe working with people who present themselves as genuine, real, and imperfect makes it easier to establish trust, facilitating healing."

News about

  • WTI crude oil weekly forecast: resistance vulnerable as values escalate anew - 07 April 2024. According to DailyForex on Sunday, 7 April, "Certainly there are tensions in the Middle East and they could escalate from here, but the buying within WTI Crude Oil may be getting fueled by growing demand for the commodity and simple speculative conditions. ", "The trend higher in WTI Crude Oil has been noticeable for a few months, but there have also been reversals lower which day traders need to respect."
  • According to FXStreet on Monday, 8 April, "Apart from this, the OPEC+ clampdown on some countries to increase compliance with output cuts, along with a strong demand outlook, acts as a tailwind for Crude Oil prices. ", "This, along with the upbeat US NFP-inspired US Dollar (USD) strength, prompts some profit-taking around Crude Oil prices, especially after the recent blowout rally witnessed over the past two months or so."
  • Crude oil forecast: continues to power higher - 08 April 2024. According to DailyForex on Monday, 8 April, "The West Texas Intermediate Crude Oil market initially pulled back during the day on Friday as we were waiting for the jobs number. ", "At this point, I fully anticipate that the WTI Crude Oil marketers looking to the $87.50 level next, followed by the $90 level above."

More news about Silver (SI).

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Clinical Catalyst Season: Big-Pharma Data Flow, Regulatory Milestones, and a Thin AI-Drug Fringe
October 2026 conferences (EASD, IGCS, NACFC, HFSA) are producing a dense run of late-stage readouts from Novo Nordisk, Lilly, Roche, Bayer, Vertex and Galderma. Regulatory milestones are scheduled behind them: the ivonescimab BLA PDUFA date on 2026-11-14, FDA acceptance of Roche's vamikibart BLA, and Scholar Rock's EMA resubmission. The AI-and-finance angle is peripheral. It consists of the AI-designed drug Rentosertib and QAIAx, a speculative microcap whose trial claims (the QIII pilot, anticipated 2027-01-01, and a patent update) are forecasts and filings rather than data, so they warrant skepticism.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,375 source documents archived
Query this data → isubstrate.com